IGF1R and breast cancer: Zinc has been reported in preclinical studies to trigger an interplay of G protein estrogen receptor with insulin-like growth factor receptor I (IGF-IR) and epidermal growth factor receptor, which results in the activation of important transduction pathways and biological responses such as proliferation and migration in breast cancer cells [6].